v3.20.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating activities    
Net income (loss) $ 1,928 $ 14,904
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 15,617 21,079
Amortization of deferred debt issuance costs 773 1,574
Stock compensation expense 2,921 3,670
Deferred income taxes (2,698) (3,416)
Release of reserve for uncertain tax positions, net 0 (421)
Loss on long-term cross currency swap 5,068 1,897
Remeasurement gain on intercompany balances (6,996) (2,264)
Loss on sale of business, net of cash surrendered 2,045 0
Changes in operating assets and liabilities:    
Accounts receivable 21,028 9,747
Inventories (10,618) 1,957
Contract assets (2,148) 8,167
Other current and non-current assets (2,833) (4,422)
Accounts payable (2,263) 503
Accrued liabilities and non-current liabilities (991) (4,441)
Income taxes payable and receivable (5,354) 3,821
Net cash provided by operating activities 15,479 52,355
Investing activities    
Purchases of property, plant and equipment (4,708) (6,701)
Sale of rental equipment 65 371
Proceeds from sale of property, plant and equipment 0 242
Net cash used in investing activities (4,643) (6,088)
Financing activities    
Proceeds from revolving credit facility 37,189 10,000
Payments on long-term debt and revolving credit facility (44,339) (46,279)
Purchase of shares from non-controlling interests 0 (4,508)
Proceeds from exercise of stock options 468 860
Repurchase of employee stock units on vesting (688) (890)
Payments on finance leases (218) (106)
Net cash used in financing activities (7,588) (40,923)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 3,057 503
Cash, cash equivalents and restricted cash at beginning of period 46,006 33,841
Cash, cash equivalents and restricted cash at end of period 52,311 39,688
Change in cash, cash equivalents and restricted cash $ 6,305 $ 5,847

Source